Marta Bianchini1, Giulia Puliani2, Virginia Scarinci3, Gaetana Cognetti4, Rosa Lauretta5, Marilda Mormando6, Francesca Servoli7, Marialuisa Appetecchia8
doi: http://dx.doi.org/10.5195/jmla.2026.2191
Volume 114, Number 2: 116-124
Received 03 2025; Accepted 10 2025
ABSTRACT
Objectives:Information prescriptions consist in making specific health care information available to patients on their disease from accredited sources, in order to help them understand and manage their disease, stimulating informed participation in health care. In the literature, a few studies have investigated the real effectiveness of prescribing information on the health management of oncological diseases. The scope of our pilot study was to investigate the effectiveness of information prescription, evaluating both patient satisfaction and perception, but also its possible impact on adherence to follow-up programs.
Methods:Prospective pilot study enrolling patients with thyroid cancer. They received informative scientific material on thyroid cancer, dispensed by clinical librarians of the Institute's Library.
Results:101 patients were enrolled (81% were women with a total mean age of 49.39 years). 26% of patients accessed the institute's library receiving patient information materials. Comparing data of people who completed the project with those who did not, no differences in sex, age and tumour characteristics were found. We found no statistical differences in terms of adherence to follow-up visits between the two groups of patients, but health information was able to effectively respond to the requests or needs of most patients. Participating patients have improved awareness and knowledge of their disease, patient-doctor relationships, adherence to treatment and communication with family members regarding their disease status, with a final positive impact on one's psychological well-being and global satisfaction obtained in 65% of people.
Conclusions:This is the first Italian study carried out in the field of oncological endocrinology, demonstrating the positive role health information has on patients' psychological health and thyroid cancer knowledge.
Keywords: Information prescription; thyroid cancer; hospital library; psychological health, mental well-being, disease self-management, health librarianship.
Health information prescription refers to providing specific evidence-based health information to patients with a diagnosed condition to help them understand and manage their own disease, thus stimulating informed participation in healthcare. [1–3] A health information prescription is written by the doctor, given to patients and/or family members, encouraging them to consult qualified and reliable scientific information on their diseases [4], based on the individual needs and specific requests of the patient [5].
This practice aims to inform the patient about their disease, allowing them to gain better knowledge of treatments and follow-up programs, with the potential to improve adherence and effectiveness. Furthermore, appropriate health information could change health behaviors and help patients make better, more informed healthcare decisions [6]. Knowledge is a critical factor in decision-making, it can improve patient health status and quality of life [7–10] and enhance doctor-patient communication [11, 12].
The practice of health information prescription has a long history [13, 14] but only recently, many governmental agencies across different countries have promoted models and materials for information prescription programs. [13] To date, most studies on health information prescription published in literature have mainly focused on chronic diseases, such as diabetes mellitus, hypertension or other metabolic diseases that can benefit from lifestyle modifications [15–18].
Most studies on information prescription were small pilot projects or case reports aimed at investigating patient or physician satisfaction through the use of surveys [12, 13, 19–28], while other clinical outcomes have not been well studied. In particular, analysis of the effectiveness of information prescription on health improvement or changes in self-management of diseases are scarce [4]. A qualitative semi-experimental study on 61 women with breast cancer, showed that after providing health information prescriptions, women improved their self-care capacity according to a questionnaire given to patients [29]. In another study of 21 diabetic patients, it was shown that information prescription improved medical services utilization, patients’ knowledge on their disease, and increased the capacity for self-care, enhanced disease management and strengthened the doctor-patient relationship [30].
Finally, some studies demonstrated that written information prescription is effective for minimizing healthcare costs [31–35]. A recent scoping review [4] published in 2022, reported that to date, there have been no studies conducted in Italy regarding health information prescriptions and that information prescription documents primarily address non-oncological health conditions. Furthermore, most of the studies published do not specifically report the exact steps involved in information prescription services, nor the specific roles of the members of the information prescription team, such as doctors, librarians and nurses.
To overcome these limitations, we conducted an Italian pilot study to evaluate the effect of providing health information prescriptions to thyroid cancer patients, since it is the most frequent endocrine neoplasia and it negatively impacts quality of life and psychological well-being [36–38]. This study aims to:
The present study was a prospective pilot study, that was conducted for patients with thyroid cancer at IRCCS Regina Elena National Cancer Institute of Rome, a Scientific Institute for Research, Hospitalization and Healthcare and one of the largest public Comprehensive Cancer Centres in Italy. The study was carried out in collaboration with the Oncological Endocrinology Unit and the Digital Library “R. Maceratini.” People eligible for this study were patients aged over 18 years who were referred to our Oncological Endocrinology Unit and had received a new diagnosis of thyroid carcinoma within the past two months.
The study was conducted under the approval of the Local Ethics Committee of IRCCS Regina Elena National Cancer Institute (reference number: RS1035/17) and all patients gave their written informed consent to participate. Patients were consecutively enrolled between January 2020 and December 2021.
After receiving the signed informed consent, Endocrinology Unit clinicians provided health information through “prescriptive information certificates.” Patients with this prescription form were then directed to first access the library, where medical librarians provided scientific and patient education material on thyroid cancer.
The material, which was previously validated by Endocrinology Unit clinicians, included brochures produced by scientific associations and societies, as well as relevant and current evidenced-based health information available from suggested websites, and scientific publications in Italian or English, including a clinical overview of thyroid cancer, its treatment options and its prognosis. Furthermore, patients had the opportunity to request additional information resources on topics of interest, either at enrollment or at a later time by directly contacting the library.
All librarians working at our Institute were trained on the type of materials to provide patients, according to protocol. Periodic meetings between librarians and clinicians took place to collect feedback and ensure consistent patient experience.
After accessing the library and reading the informative material, patients were asked to fill out a pilot-tested questionnaire on overall project satisfaction, subjective evaluation of the project’s usefulness, quality of scientific material received, and self-reported emotions and psychological impact of information prescription, as well as possible impact of the information prescription project on self-management of disease. The questionnaire was created for this study and included both multiple choice and free-text questions (Appendix A, Supplementary Figure 1).
For each patient enrolled in the study, demographic and clinical data were collected from medical records and entered into a database for subsequent analysis. We also collected data on time from study enrollment to first accessing the digital library, topics of additional information requested by patients, and patients’ evaluations captured from questionnaires.
After completing the study, participants were divided into two groups: Group A included patients who accessed the library to receive materials and read and completed the questionnaire; Group B comprised of patients who did not go to the library but received standard information only from their endocrinologist. At least 18 months after enrollment, data on follow-up adherence were collected. Adherence was determined based on the number of missed outpatient visits or cancellations.
Categorical variables of interest were expressed as frequencies and percentage values while continuous variables were expressed as mean ± standard deviation or median and minimum-maximum range, as appropriate. We used the Pearson’s chi-square to assess categorical variables; for continuous variables the Shapiro-Wilk test was used, and the Mann-Whitney test was carried out for non-normally distributed variables via the Statistical Packages for Social Sciences (SPSS version 21.0). p values of <0.05 were considered statistically significant. Since this is a pilot study, no calculation for sample size was performed.
In the recruitment timeframe, a total of 101 consecutive patients met inclusion criteria and were enrolled in the study. 82 patients were female (81%) and 19 were male (19%), with a mean age of 49.39 ± 13.59 years. Most patients were affected by papillary thyroid cancer. Most patients (98%) were staged according to TNM 8 edition as stage I. None of the patients had distant metastases at diagnosis.
After surgery (thyroidectomy or emi-thyroidectomy) only clinical and radiological follow-ups were suggested to 87 patients (86%), while for 14 patients (14%) radioiodine therapy (I-131 Therapy) was indicated, in accordance with current guidelines [39, 40].
Patient characteristics are summarized in Table 1.
Table 1Patient characteristics.
| Total patients enrolled (n=101) | Group A (n=26) | Group B (n=75) | p | |
|---|---|---|---|---|
| Age | 49.39 ± 13.59 | 47.38 ± 13.65 | 50.08 ± 13.6 | 0.386* |
| Sex | 19 M (19%) 82 F (81%) |
3 M (11.5%) 23 F (88.5%) |
16 M (21.3%) 59 F (78.7%) |
0.386§ |
| Stage | Stage I: 99 (98%) Stage II: 2 (2%) |
Stage I: 26/26 (100%) | Stage I: 73/75 (97%) Stage II: 2/75 (3%) |
- |
| Histology | Papillary TC: 94 (93%) Aggressive tumors: -Aggressive Papillary TC: 3 (3%) -Follicular TC: 3 (3%) -Medullary TC: 1 (1%) |
24 (92%) 2 (8%) |
70 (93%) 5 (7%) |
0.859§ |
| T | 1A:58 (57%) 1B: 34 (34%) 2:7 (7%) 3: 1 (1%) 4: 1 (1%) |
1A: 15 (57.7%) 1B: 10 (38.5%) 2: 1 (3.8%) |
1A: 43 (57.3%) 1B: 24 (32%) 2: 6 (8%) 3: 1 (1.3%) 4: 1 (1.3%) |
0.842§ |
| N | 0: 86 (85%) 1A: 6 (6%) 1B: 9 (9%) |
0: 22 (84.6%) 1A: 2 (7.7%) 1B: 2 (7.7%) |
0: 64 (85.3%) 1A: 4 (5.3%) 1B: 7 (9.3%) |
0.887§ |
| Multi-focality of primary tumour | No: 80 (79.2%) Yes: 21 (20.8%) |
No: 22 (84.6%) Yes: 4 (15.4%) |
No: 58 (77.33%) Yes: 17 (23%) |
0.578§ |
| Therapy | Surgery: 87 (86%) Surgery + I-131:14 (14 %) | Surgery: 22 (85%) Surgery + I-131: 4 (15%) |
Surgery: 65 (87%) Surgery + I-131: 10 (13%) |
0.752§ |
| Follow up at our center | Yes: 91 No: 10 |
Yes: 20 No: 6 |
Yes: 71 No: 4 |
n. a. |
| All visits | 76/91 (83.5%) | 17/20 (85%) | 59/71 (83.1%) | 0.633§ |
| Missed 1 app | 12/91 (13.2%) | 3/20 (15%) | 9/71 (12.7%) | |
| Missed 2 app | 3/91 (3.3%) | 0/20 (0%) | 3/71 (4.2%) |
To assess the need for patient health information, we calculated the percentage of patients who completed all the steps of the health information prescription program.
Among the 101 patients enrolled, 26 patients (26%) visited the library and completed the questionnaire, suggesting a personal need for health information.
Regarding the time from enrolment to first library access, most patients first accessed the library on the day they enrolled (20/26 patients), while 3 patients accessed the library within a week and 3 patients within a month.
Considering gender differences, 23 women (28%) and 3 men (16%) accessed the library. People who accessed the library were younger (mean age of group A: 47.38 years; group B: 50.08 years), although this is not statistically significant.
In comparing the clinical data of people who accessed the library to those who did not, there were no differences between the two groups in disease characteristics with regards to histology, staging and prescribed treatment.
To assess follow-up adherence, we narrowed the analysis to patients with a minimum of 18 months of follow-up at our Oncological Endocrinology Unit (91/101 patients). Other patients were considered lost at follow-up.
Most patients (76/91, 83.5%) attended all scheduled outpatient visits, while a minority (15/91, 16.5%) missed 1 or more appointments. There were no statistically significant differences between the two groups: in group A, 85% of patients (17/20) attended all visits compared to 83.1% (59/71) of group B.
Regarding the type of information additionally requested by 18 of the 26 patients, the topics of greatest interest were: nutrition (8, 44%); complementary therapy or rehabilitation (5, 28%); prevention of disease and preventive health measures (2, 11%), rights and legal aspects of the oncological patients (1, 6%); psychological aspects (2, 11%), as reported in Supplementary Figure 2. From the results of the anonymous questionnaire regarding overall satisfaction, 65% (17/26) were very satisfied or satisfied, 23% (6/26) neutral and 12 % (3/26) dissatisfied with their involvement in the project. The information was able to respond effectively to the requests or needs according to most patients (65% of patients, 17/26). Moreover, 69% of patients (18/26) considered health information of good quality (completeness and clarity), 19% (5/26) deemed it sufficiently clear and complete while 12% (3/26) instead regarded it slightly clear and complete. 54% of patients (14/26) claimed the health information prescription was very useful, for 42% (11/26) it was quite useful and for 4% (1/26) a little useful.
In the free text for added patients’ notes, it was observed that most scientific materials were clear and simple, except for the documents written in English.
For most patients (69%, 18/26), the prescription of health information increased awareness and knowledge of their condition and enhanced patient-physician communication, allowing them to ask more detailed questions. For a minority of patients (19%, 5/26), receiving clinical information improved adherence to treatment and enhanced communication with family members about their own disease status, as reported in Appendix A, Supplementary Figure 3.
Regarding the psychological impact, the main emotions felt after receiving information were comfort and encouragement for 69% of patients (18/26), safety and awareness for 88% of patients (23/26), 23% of patients (6/26) replied that information caused a little bit of anxiety and worry, and only 4% of patients (1/26) only a little bit of discouragement (Appendix A, Supplementary Figure 4).
Among personal comments in the free text field, most patients reported satisfaction with the project that enhanced awareness of their own disease and encouraged their health status. Many comments highlighted the project’s utility on diagnostic-therapeutic pathways and disease self-management (Appendix A, Supplementary Figure 5).
Health information prescription belongs in patient-centered health care services; it is an innovative approach that allows to provide appropriate information at the right time to help patients in the management of the disease [41, 42]. Although health information prescription is commonly considered a good practice, objective demonstrations of its effectiveness are scarce.
Previous studies did not report the relationship between various demographic variables and participation in health prescription information. To identify the categories of patients who are most interested in the health information prescription project, we assessed both age and sex. We found that a higher percentage of women accessed the library (28% women versus 16% men) even if not statistically significant. This trend is expected if we consider that generally, women pay greater attention to their health compared to men [43], and have a higher rate of health information-seeking behavior [44]. The lack of statistical significance could be related to a small group of patients.
Socio-cultural factors could influence active participation in information prescription projects. Patients with a lower economic status and socio-cultural level generally seek information less frequently [45]. Unfortunately, data regarding the education level of patients are lacking in our study, albeit our patients reported the English language of scientific texts as a barrier to health information, which confirmed previous data present in literature [3, 46].
Unlike previous studies [47–51], we correlated the information-seeking behavior to the cancer histotype or stage. We found no differences and hypothesize that a tumour diagnosis has the same impact on the information-seeking behavior of patients, regardless of histotype or stage. We also investigated clinical consequences as the impact of prescription information on follow up adherence. The study did not demonstrate any significant changes between participating and non-participating patients in terms of adherence to follow-up care. This may be due the fear of neoplastic recurrence.
Our results, in alignment with previous studies [52], showed patient satisfaction and positive effect perceived by patients on self-care. The questionnaires illustrated that patients perceived an improvement in awareness and knowledge of their disease condition. This resulted in better communication with physicians, in alignment with previous studies[17, 29, 53]. Finally, from a psychological point of view, the main emotions generated from receiving information were comfort, encouragement, and safety, suggesting that, overall information prescription could have a favourable impact on the quality of life of patients affected by endocrine neoplasms.
The main limitations of our study are the small number of enrolled patients who accessed the library, which limits generalizability and may not be sufficient to identify the real effectiveness of the prescription on changes in patient adherence to follow-up programs. There are several possible reasons for low participation, including that the library is physically located outside the Hospital and that many patients were enrolled during the period of the Covid-19 pandemic where many measures greatly restricted access to the library. Another possible explanation is the growing spread of Internet usage in recent decades, [54, 55] including among the elderly, which could reduce interest in seeking other forms of information. As a single-arm study designed to assess patients’ participation in an information prescription program, our study is not randomized.
Future research should consider focusing on other oncological conditions, controlling or adjusting for patients’ education level, and using digital or remote delivery for improving adherence, in addition to having larger sample sizes and investigating other aspects of clinical management.
Nonetheless, the study also has important strengths: this is the first study evaluating the impact of information prescription on adherence to follow-up (instead of only the impact on satisfaction or psychological parameters) and that includes stratification of patients based on demographic and disease-related factors.
Moreover, for the first time, health information prescription study has been carried out in the Italian endocrine oncology setting. This pilot study allowed the research team to investigate the conceptual feasibility of health information prescription in patients affected by thyroid cancer and has contributed to understanding the impact of information prescription services on health-care outcomes. Our study demonstrated an overall satisfaction in thyroid cancer patients, who perceived to have greater understanding of their disease; better communication with physicians; and improvement in self-reported feelings of comfort, encouragement and safety. Based on these promising results, we encourage the application and widespread adoption of this good clinical practice tool in other medical fields, particularly in other cancers.
The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Local Ethic Committee of IRCCS Regina Elena National Cancer Institute (reference number: RS1035/17, and date of approval: 12 December 2017).
All the participants signed an informed consent form.
The authors report there are no competing interests to declare.
Authors have contributed to the manuscript preparation as follows: M. Bianchini: conceptualization and design of the work, investigation, study conduction, data collection, initial data analysis, writing original draft; G. Puliani: data curation, formal analysis, statistical analysis and review of the article; R. Lauretta and M. Mormando: data curation and investigation, V. Scarinci: data curation and review & editing; F. Servoli: review & editing and validation; G. Cognetti: conceptualization; M. Appetecchia: study conceptualization and supervision, review & editing. All authors read and approved the final article.
All data generated or analyzed are included in this article. Further enquiries can be directed to the corresponding author. Data associated with this article area available at https://gbox.garr.it/.
Appendix A: Survey Questions & Figures
1. Mettler, M. and D. W. Kemper. “Information therapy: Health education one person at a time.” Health Promot Pract 4 (2003): 214–7. http://dx.doi.org/10.1177/1524839903004003004
. http://www.ncbi.nlm.nih.gov/pubmed/14610991.
2. Kemper, D. W. and M. Mettler. “Information therapy: Prescribing the right information to the right person at the right time.” Manag Care Q 10 (2002): 43–6. http://www.ncbi.nlm.nih.gov/pubmed/12561393.
3. Gavgani, V. Z. and A. R. Shiramin. “Physician directed information prescription service (ips): Barriers and drivers.” Aslib Proceedings 65 (2013): 224–41. http://dx.doi.org/10.1108/00012531311330629
.
4. Okhovati, M., Z. Bagherinezhad, V. Z. Gavgani and H. Safizadeh. “Physician-directed information prescription service. A scoping review.” Patient Educ Couns 105 (2022): 3369–80. http://dx.doi.org/10.1016/j.pec.2022.08.002
. http://www.ncbi.nlm.nih.gov/pubmed/35985907.
5. D.W. Kemper, M. M. “Information therapy: Prescribed information as a reimbursable medical service.” Healthwise (2002): ISBN-10 : 1877930881.
6. Mettler, M. and D. W. Kemper. “Information therapy: The strategic role of prescribed information in disease self-management.” Stud Health Technol Inform 121 (2006): 373–83. http://www.ncbi.nlm.nih.gov/pubmed/17095835.
7. Greenfield, S., S. H. Kaplan, J. E. Ware, Jr., E. M. Yano and H. J. Frank. “Patients' participation in medical care: Effects on blood sugar control and quality
of life in diabetes.” J Gen Intern Med 3 (1988): 448–57. http://dx.doi.org/10.1007/BF02595921
. http://www.ncbi.nlm.nih.gov/pubmed/3049968.
8. Beisecker, A. E. and T. D. Beisecker. “Patient information-seeking behaviors when communicating with doctors.” Med Care 28 (1990): 19–28. http://dx.doi.org/10.1097/00005650-199001000-00004
. http://www.ncbi.nlm.nih.gov/pubmed/2296214.
9. Gleason-Comstock, J., A. Streater, J. Ager, A. Goodman, A. Brody, L. Kivell, A. Paranjpe, J. Vickers, L. Mango, R. Dawood, et al. “Patient education and follow-up as an intervention for hypertensive patients discharged
from an emergency department: A randomized control trial study protocol.” BMC Emerg Med 15 (2015): 38. http://dx.doi.org/10.1186/s12873-015-0052-3
. http://www.ncbi.nlm.nih.gov/pubmed/26691646.
10. Hester, K. L. M., J. Newton, T. Rapley and A. De Soyza. “Patient information, education and self-management in bronchiectasis: Facilitating
improvements to optimise health outcomes.” BMC Pulm Med 18 (2018): 80. http://dx.doi.org/10.1186/s12890-018-0633-5
. http://www.ncbi.nlm.nih.gov/pubmed/29788946.
11. Petruschke, I., F. Salm, M. Kaufmann, A. Freytag, J. Gensichen, M. Behnke, T. S. Kramer, R. Hanke, P. Gastmeier, S. Schneider, et al. “Evaluation of a multimodal intervention to promote rational antibiotic use in primary
care.” Antimicrob Resist Infect Control 10 (2021): 66. http://dx.doi.org/10.1186/s13756-021-00908-9
. http://www.ncbi.nlm.nih.gov/pubmed/33823926.
12. Siegel, E. R., R. A. Logan, R. L. Harnsberger, K. Cravedi, J. A. Krause, B. Lyon, K. Hajarian, J. Uhl, A. Ruffin and D. A. Lindberg. “Information rx: Evaluation of a new informatics tool for physicians, patients, and
libraries.” Inf Serv Use 26 (2006): 1–10. http://dx.doi.org/10.3233/isu-2006-26101
. http://www.ncbi.nlm.nih.gov/pubmed/17060946.
13. McKnight, M. “Information prescriptions, 1930-2013: An international history and comprehensive review.” J Med Libr Assoc 102 (2014): 271–80. http://dx.doi.org/10.3163/1536-5050.102.4.008
. http://www.ncbi.nlm.nih.gov/pubmed/25349545.
14. Timm, D. F. and D. Jones. “The information prescription: Just what the doctor ordered!” Journal of Hospital Librarianship (2011): 11(4), 358–65. https://doi.org/10.1080/15323269.2011.611110.
15. Jia, W., M. Sun, G. Huang, B. Payton and W. Yu. “The indirect effects of health information seeking on health lifestyle: Health literacy
matters.” Health Educ Behav (2024): 10901981241278587. http://dx.doi.org/10.1177/10901981241278587
. http://www.ncbi.nlm.nih.gov/pubmed/39308078.
16. Giuse, N. B., T. Y. Koonce, A. B. Storrow, S. V. Kusnoor and F. Ye. “Using health literacy and learning style preferences to optimize the delivery of health
information.” J Health Commun 17 Suppl 3 (2012): 122-40. http://dx.doi.org/10.1080/10810730.2012.712610
. http://www.ncbi.nlm.nih.gov/pubmed/23030566.
17. Koonce, T. Y., N. B. Giuse, S. V. Kusnoor, S. Hurley and F. Ye. “A personalized approach to deliver health care information to diabetic patients in
community care clinics.” J Med Libr Assoc 103 (2015): 123–30. http://dx.doi.org/10.3163/1536-5050.103.3.004
. http://www.ncbi.nlm.nih.gov/pubmed/26213503.
18. Rylance, A. “Using information prescriptions in diabetes.” Nurs Times 111 (2015): 12–3. http://www.ncbi.nlm.nih.gov/pubmed/26285435.
19. Dodson, L., R. Bisnauth and N. James. “Information is power.” Nurs Manag (Harrow) 15 (2008): 14–9. http://dx.doi.org/10.7748/nm.15.4.14.s17
. http://www.ncbi.nlm.nih.gov/pubmed/18669414.
20. D'Alessandro, D. M., C. D. Kreiter, S. L. Kinzer and M. W. Peterson. “A randomized controlled trial of an information prescription for pediatric patient
education on the internet.” Arch Pediatr Adolesc Med 158 (2004): 857–62. http://dx.doi.org/10.1001/archpedi.158.9.857
. http://www.ncbi.nlm.nih.gov/pubmed/15351750.
21. Beaudoin, D. E., N. Longo, R. A. Logan, J. P. Jones and J. A. Mitchell. “Using information prescriptions to refer patients with metabolic conditions to the
genetics home reference website.” J Med Libr Assoc 99 (2011): 70–6. http://dx.doi.org/10.3163/1536-5050.99.1.012
. http://www.ncbi.nlm.nih.gov/pubmed/21243058.
22. Burke, M., P. Carey, L. Haines, A. P. Lampson and F. Pond. “Implementing the information prescription protocol in a family medicine practice:
A case study.” J Med Libr Assoc 98 (2010): 228–34. http://dx.doi.org/10.3163/1536-5050.98.3.011
. http://www.ncbi.nlm.nih.gov/pubmed/20648257.
23. Coberly, E., S. A. Boren, J. W. Davis, A. L. McConnell, R. Chitima-Matsiga, B. Ge, R. A. Logan, W. C. Steinmann and R. H. Hodge. “Linking clinic patients to internet-based, condition-specific information prescriptions.” J Med Libr Assoc 98 (2010): 160–4. http://dx.doi.org/10.3163/1536-5050.98.2.009
. http://www.ncbi.nlm.nih.gov/pubmed/20428282.
24. Chesser, A. K., N. C. Woods, A. A. Davis and C. J. Bowers. “Prescribing information therapy: Opportunity for improved physician-patient communication
and patient health literacy.” J Prim Care Community Health 3 (2012): 6–10. http://dx.doi.org/10.1177/2150131911414712
. http://www.ncbi.nlm.nih.gov/pubmed/23804848.
25. Coberly, E., S. A. Boren, M. Mittal, J. W. Davis, C. Scoville, R. Chitima-Matsiga, B. Ge, A. Cullina, R. A. Logan, W. C. Steinmann, et al. “Medlineplus-based health information prescriptions: A comparison of email vs paper
delivery.” Inform Prim Care 20 (2012): 197–205. http://dx.doi.org/10.14236/jhi.v20i3.25
. http://www.ncbi.nlm.nih.gov/pubmed/23710844.
26. Keene, N., A. Chesser, T. A. Hart, P. Twumasi-Ankrah and D. D. Bradham. “Preliminary benefits of information therapy.” J Prim Care Community Health 2 (2011): 45–8. http://dx.doi.org/10.1177/2150131910385005
. http://www.ncbi.nlm.nih.gov/pubmed/23804662.
27. Kinnane, N. A. “Evaluation of a hospital-based cancer information and support centre.” Support Care Cancer 20 (2012): 287–300. http://dx.doi.org/10.1007/s00520-010-1071-y
. http://www.ncbi.nlm.nih.gov/pubmed/21225290.
28. Leisey, M. R. and J. P. Shipman. “Information prescriptions: A barrier to fulfillment.” J Med Libr Assoc 95 (2007): 435–8. http://dx.doi.org/10.3163/1536-5050.95.4.435
. http://www.ncbi.nlm.nih.gov/pubmed/17971891.
29. Latifi, M., N. Alishan Karami, M. Beiraghdar, F. Maraki and L. Allahbakhshian Farsani. “Impact of health information prescription on self-care of women with breast cancer.” Adv Biomed Res 7 (2018): 139. http://dx.doi.org/10.4103/abr.abr_142_18
. http://www.ncbi.nlm.nih.gov/pubmed/30505810.
30. Nabiolahi, A., S. Sedghi, R. Aghili and L. Nemati-Anaraki. “Personalization of health information prescription in diabetes clinical setting: A
qualitative study.” J Educ Health Promot 10 (2021): 103. http://dx.doi.org/10.4103/jehp.jehp_688_20
. http://www.ncbi.nlm.nih.gov/pubmed/34084850.
31. Kazemi Majd, F., V. Z. Gavgani, A. Golmohammadi and A. Jafari-Khounigh. “Effect of physician prescribed information on hospital readmission and death after
discharge among patients with health failure: A randomized controlled trial.” Health Informatics J 27 (2021): 1460458221996409. http://dx.doi.org/10.1177/1460458221996409
. http://www.ncbi.nlm.nih.gov/pubmed/33657912.
32. Zarea Gavgani, V., F. Kazemi Majd, S. Nosratnejad, A. Golmohammadi and H. Sadeghi-Bazargani. “The efficacy of written information intervention in reduction of hospital readmission
cost in patients with heart failure; a systematic review and meta-analysis.” J Cardiovasc Thorac Res 7 (2015): 1–5. http://dx.doi.org/10.15171/jcvtr.2015.01
. http://www.ncbi.nlm.nih.gov/pubmed/25859308.
33. Lopez Cabezas, C., C. Falces Salvador, D. Cubi Quadrada, A. Arnau Bartes, M. Ylla Bore, N. Muro Perea and E. Homs Peipoch. “Randomized clinical trial of a postdischarge pharmaceutical care program vs regular
follow-up in patients with heart failure.” Farm Hosp 30 (2006): 328–42. http://dx.doi.org/10.1016/s1130-6343(06)74004-1
. http://www.ncbi.nlm.nih.gov/pubmed/17298190.
34. Atienza, F., M. Anguita, N. Martinez-Alzamora, J. Osca, S. Ojeda, L. Almenar, F. Ridocci, F. Valles, J. A. de Velasco and P. S. Group. “Multicenter randomized trial of a comprehensive hospital discharge and outpatient
heart failure management program.” Eur J Heart Fail 6 (2004): 643–52. http://dx.doi.org/10.1016/j.ejheart.2003.11.023
. http://www.ncbi.nlm.nih.gov/pubmed/15302014.
35. Rich, M. W., V. Beckham, C. Wittenberg, C. L. Leven, K. E. Freedland and R. M. Carney. “A multidisciplinary intervention to prevent the readmission of elderly patients with
congestive heart failure.” N Engl J Med 333 (1995): 1190–5. http://dx.doi.org/10.1056/NEJM199511023331806
. http://www.ncbi.nlm.nih.gov/pubmed/7565975.
36. Dong, Z., X. Zhan, W. Liu, D. Rao, M. Yang, Y. Peng, Y. Su and R. Cheng. “Factors influencing the quality of life in survivors of differentiated thyroid cancer
based on patient-reported outcomes: A single-center cross-sectional study.” Front Endocrinol (Lausanne) 16 (2025): 1565633. http://dx.doi.org/10.3389/fendo.2025.1565633
. http://www.ncbi.nlm.nih.gov/pubmed/40370771.
37. Wang, Z., C. Chen, J. Lu and Z. Liu. “The current state and influencing factors of negative social expectations among thyroid
cancer patients: A single-center cross-sectional analysis.” Front Psychol 16 (2025): 1599652. http://dx.doi.org/10.3389/fpsyg.2025.1599652
. http://www.ncbi.nlm.nih.gov/pubmed/40420988.
38. Husson, O., H. Poort, U. M. Sansom-Daly, R. Netea-Maier, T. Links and F. Mols. “Psychological distress and illness perceptions in thyroid cancer survivors: Does age
matter?” J Adolesc Young Adult Oncol 9 (2020): 375–83. http://dx.doi.org/10.1089/jayao.2019.0153
. http://www.ncbi.nlm.nih.gov/pubmed/31990604.
39. Haugen, B. R., E. K. Alexander, K. C. Bible, G. M. Doherty, S. J. Mandel, Y. E. Nikiforov, F. Pacini, G. W. Randolph, A. M. Sawka, M. Schlumberger, et al. “2015 american thyroid association management guidelines for adult patients with thyroid
nodules and differentiated thyroid cancer: The american thyroid association guidelines
task force on thyroid nodules and differentiated thyroid cancer.” Thyroid 26 (2016): 1–133. http://dx.doi.org/10.1089/thy.2015.0020
. http://www.ncbi.nlm.nih.gov/pubmed/26462967.
40. Filetti, S., C. Durante, D. Hartl, S. Leboulleux, L. D. Locati, K. Newbold, M. G. Papotti, A. Berruti and E. G. C. E. a. clinicalguidelines@esmo.org. “Thyroid cancer: Esmo clinical practice guidelines for diagnosis, treatment and follow-updagger.” Ann Oncol 30 (2019): 1856–83. http://dx.doi.org/10.1093/annonc/mdz400
. http://www.ncbi.nlm.nih.gov/pubmed/31549998.
41. Wilson, D., Bateman, H., & Bailey, P. “Early experience of the contribution of an information specialist within a primary healthcare team: A partnership venture between library and healthcare services.” Journal of Librarianship and Information Science 36(3) (2004): 127-34. https://doi.org/10.1177/0961000604048915.
42. Kellerman, R. and L. Kirk. “Principles of the patient-centered medical home.” Am Fam Physician 76 (2007): 774–5. http://www.ncbi.nlm.nih.gov/pubmed/17910291.
43. Cortese, D. A. “A vision of individualized medicine in the context of global health.” Clin Pharmacol Ther 82 (2007): 491–3. http://dx.doi.org/10.1038/sj.clpt.6100390
. http://www.ncbi.nlm.nih.gov/pubmed/17952101.
44. Atkinson, N. L., S. L. Saperstein and J. Pleis. “Using the internet for health-related activities: Findings from a national probability
sample.” J Med Internet Res 11 (2009): e4. http://dx.doi.org/10.2196/jmir.1035
. http://www.ncbi.nlm.nih.gov/pubmed/19275980.
45. Czaja, R., C. Manfredi and J. Price. “The determinants and consequences of information seeking among cancer patients.” J Health Commun 8 (2003): 529–62. http://dx.doi.org/10.1080/716100418
. http://www.ncbi.nlm.nih.gov/pubmed/14690888.
46. Nabiolahi A., S. S., Aghili R., Nemati-Anaraki L. “Health information prescription system for non communicable diseases: A systematic
review and thematic analysis.” Russian Open Medical Journal volume 9 - Issue 4 (2020): http://dx.doi.org/10.15275/rusomj.2020.0406
47. Christalle, E., J. M. Zill, W. Frerichs, M. Harter, Y. Nestoriuc, J. Dirmaier and I. Scholl. “Assessment of patient information needs: A systematic review of measures.” PLoS One 14 (2019): e0209165. http://dx.doi.org/10.1371/journal.pone.0209165
. http://www.ncbi.nlm.nih.gov/pubmed/30703103.
48. Alamanou, G. D., A. S. Balokas, V. N. Fotos, E. Patiraki and H. Brokalaki. “Information needs of cancer patients: Validation of the greek cassileth's information
styles questionnaire.” Eur J Oncol Nurs 20 (2016): 49–57. http://dx.doi.org/10.1016/j.ejon.2015.11.002
. http://www.ncbi.nlm.nih.gov/pubmed/26700140.
49. Long, D., H. S. Friedrich-Nel and G. Joubert. “Patients' informational needs while undergoing brachytherapy for cervical cancer.” Int J Qual Health Care 28 (2016): 200–8. http://dx.doi.org/10.1093/intqhc/mzv119
. http://www.ncbi.nlm.nih.gov/pubmed/26803540.
50. Heidari, H. and M. Mardani-Hamooleh. “Cancer patients' informational needs: Qualitative content analysis.” J Cancer Educ 31 (2016): 715–20. http://dx.doi.org/10.1007/s13187-015-0887-z
. http://www.ncbi.nlm.nih.gov/pubmed/26205979.
51. Khoshnood, Z., M. Dehghan, S. Iranmanesh and M. Rayyani. “Informational needs of patients with cancer: A qualitative content analysis.” Asian Pac J Cancer Prev 20 (2019): 557–62. http://dx.doi.org/10.31557/APJCP.2019.20.2.557
. http://www.ncbi.nlm.nih.gov/pubmed/30803220.
52. Koonce, TY; NB, Giuse; and AB, Storrow. “A pilot study to evaluate learning style-tailored information prescriptions for hypertensive
emergency department patients.” J Med Libr Assoc 99 (2011): 280–9. http://dx.doi.org/10.3163/1536-5050.99.4.005
. http://www.ncbi.nlm.nih.gov/pubmed/22022222.
53. Gavgani, V, and M Mahami-Oskouei. “The assessment of information prescription service to patients with heart valve disease; applying user‘s satisfaction study.” (2012):
54. Jia, X., Y. Pang and L. S. Liu. “Online health information seeking behavior: A systematic review.” Healthcare (Basel) 9 (2021): http://dx.doi.org/10.3390/healthcare9121740
. http://www.ncbi.nlm.nih.gov/pubmed/34946466.
55. Dalmer, N. K. “Questioning reliability assessments of health information on social media.” J Med Libr Assoc 105 (2017): 61–68. http://dx.doi.org/10.5195/jmla.2017.108
. http://www.ncbi.nlm.nih.gov/pubmed/28096748.
Marta Bianchini, 1 marta.bianchini@ifo.it, Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Giulia Puliani, 2 giulia.puliani@ifo.it, Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Virginia Scarinci, 3 virginia.scarinci@ifo.it, Digital Library R. Maceratini, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Gaetana Cognetti, 4 gaetana.cognetti@ifo.it, Digital Library R. Maceratini, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Rosa Lauretta, 5 rosa.lauretta@ifo.it, Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Marilda Mormando, 6 marilda.mormando@ifo.it, Oncological Endocrinology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Francesca Servoli, 7 francesca.servoli@ifo.it, Digital Library R. Maceratini, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Marialuisa Appetecchia, 8 marialuisa.appetecchia@ifo.it, IRCCS Regina Elena National Cancer Institute, Rome, Italy
© 2026 Marta Bianchini, Giulia Puliani, Virginia Scarinci, Gaetana Cognetti, Rosa Lauretta, Marilda Mormando, Francesca Servoli, Marialuisa Appetecchia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal of the Medical Library Association, VOLUME 114, NUMBER 2, April 2026